Neuroscience20 Miami 2026 | Partnerships
Science moves further when partners move together.
Join the organizations advancing brain, spine and mental health through clinical breakthroughs, international collaboration, technology and patient advocacy. Discover the N20 Miami ecosystem and start a meaningful partnership conversation.
A global conversation about the future of brain health.


Sunday, December 13, 2026 · Pullman Miami Airport Hotel · Miami, Florida
Partnerships With Purpose
Welcoming innovation that changes lives.
We are grateful to Paradromics and Plug and Play for the ingenuity, care and collaborative spirit they bring to Neuroscience20 Miami. Their work connects breakthrough ideas with the people who can bring them into the world.
Paradromics
Helping people communicate through breakthrough neurotechnology.
Paradromics is developing Connexus, an investigational high-data-rate brain-computer interface designed to translate intended speech-related neural signals into text and synthesized speech. Its Connect-One clinical study is advancing human communication technology and patient-centered neuroengineering.
Paradromics has reported real-time speech and text communication with its fully implanted Connexus BCI during its Connect-One early feasibility study. The work makes a highly tangible patient-centered case for translating neural interfaces into communication and independence.
We warmly welcome Paradromics as an N20 partner. Their commitment to communication, independence and patient-centered neuroengineering brings purpose to innovation.
Plug and Play
Connecting bold ideas with the people who can scale them.
Plug and Play connects startups, corporations, investors and research organizations through innovation programs and venture investment. Its AI Centers of Excellence support practical AI collaboration, and its healthcare and deeptech network helps emerging technologies reach partners and markets.
Plug and Play connects promising startups with investors and industry organizations. Its AI Centers of Excellence provide applied collaboration opportunities, while its healthcare and deeptech network helps N20 participants explore pathways from science to scalable innovation.
We are grateful to Plug and Play, Saeed Amidi and Dr. Jon Albo for helping connect scientists, entrepreneurs, investors and industry leaders around ideas that can improve lives.
With Gratitude
Every partner moves the mission forward.
From brain mapping and cell therapy to responsible AI, patient advocacy, research and investment, discover the organizations and representatives shaping N20 Miami.
Aramis Therapeutics
Turning therapeutic science into progress for patients.
Aramis Therapeutics is a Los Angeles biotechnology venture focused on accelerating therapeutic innovation for neurological disorders and cancer. Its work connects brain health research with regenerative medicine, medical technology, advanced diagnostics and the translation of promising discoveries into patient-focused solutions.
Its mission brings innovators from multiple biomedical disciplines together around challenges such as cancer and neurological disorders. The N20 connection is the opportunity for researchers, clinicians and technology builders to discuss how discoveries become practical tools for patients.
We are grateful to Aramis Therapeutics for bringing a translational and entrepreneurial perspective to the future of neurological treatment.
World Brain Mapping Foundation
Supporting the discoveries that improve lives.
The World Brain Mapping Foundation (WBMF) is a 501(c)(3) charitable organization supporting multidisciplinary brain, spine and mental health initiatives. It helps connect scientific discovery with education, public awareness, philanthropic engagement and the translation of emerging neurotechnologies into better care for civilians, veterans and wounded service members.
WBMF builds bridges between scientific talent, community support and global brain-health causes. Its participation connects the event with education, philanthropy and initiatives that make advanced science more accessible to patients and communities.
We appreciate the Foundation’s continued commitment to education, philanthropy and meaningful impact for patients and families.
Society for Brain Mapping and Therapeutics
Connecting disciplines. Accelerating brain health.
Founded in 2004, the Society for Brain Mapping and Therapeutics (SBMT) is a multidisciplinary 501(c)(6) professional society connecting physicians, neuroscientists, engineers, entrepreneurs and policymakers. Through scientific consortia, conventions, education and global initiatives including Neuroscience20, SBMT advances brain mapping, neurotechnology, diagnostic tools and therapies for neurological disorders.
SBMT convenes multidisciplinary scientists, physicians, engineers and innovators, including the consortia that connect emerging neurotechnology with clinical questions. Its cross-sector network helps N20 move from dialogue toward meaningful collaboration.
We celebrate the scientists, clinicians, innovators and leaders who make the SBMT community a place for discovery and connection.
Üsküdar University, Türkiye
Where neuroscience, education and clinical care meet.
Based in Istanbul, Üsküdar University connects education and research in behavioral health, psychology, neuroscience and bioengineering. Its academic and clinical ecosystem, including affiliated NPİSTANBUL, spans neuroimaging, neurostimulation, brain-computer interfaces and neuropsychiatry. Its scientists contribute to international brain health dialogue through Neuroscience20.
Üsküdar University contributes an academic and clinical perspective spanning neuroscience, behavioral health, imaging and neuropsychiatry. Its global relationships support cross-border exchange in education, research and the translation of new ideas.
Thank you to Üsküdar University for joining this international exchange with a commitment to science, education and collaboration.
Celularity
Exploring the next frontier of cellular medicine.
Celularity is a biotechnology company developing regenerative and cellular medicine using the biology of the postpartum placenta. Its research and product platforms include off-the-shelf allogeneic cell therapies and placental-derived biomaterials, with work involving natural killer cells, T cells and mesenchymal-like stromal cells for important unmet medical needs.
Celularity is advancing scalable placental-derived cellular and biomaterial technologies, including NK, T-cell and stromal-cell research. Its role in the N20 ecosystem brings therapeutic science and biotech manufacturing into conversations about regenerative medicine.
We welcome Celularity’s expertise in regenerative medicine and are grateful for the scientific perspective its team brings to N20.
The Neurobusiness Corporation
Understanding the human mind through measurable science.
A Los Angeles-based neuroscience and applied AI company developing predictive digital twins of target consumers. Its neuromarketing research combines EEG, eye tracking, galvanic skin response (GSR) and ECG data to study attention, emotional response and consumer decision patterns. Its goal is to help brands make more evidence-based marketing and product decisions.
Led by scientific founder and CEO Arifa Kokab (MScEng, MMSc, MBA), The Neurobusiness Corporation applies multimodal signals to study attention, emotion and human decision-making. Arifa is also an N20 Selected Trailblazer and Panelist.
We are grateful to The Neurobusiness Corporation for connecting neuroscience, AI and human-centered innovation within the N20 community.
Intelliforge.AI
Engineering AI solutions with neuroscience at the center.
Intelliforge.AI is the applied AI engineering and automation division of The Neurobusiness Corporation. It develops custom AI systems, human-governed agentic workflows and intelligent automation for organizations and research teams. Its technical work also connects computational neuroscience with emerging neurotechnology, including brain-computer interfaces and robotics.
Intelliforge.AI, founded and led by Arifa Kokab, develops human-governed AI workflows and technical systems for research and organizations, with interests spanning brain-computer interfaces and robotics. Arifa is an N20 Selected Trailblazer and Panelist.
We welcome Intelliforge.AI’s engineering perspective and its commitment to practical, thoughtfully governed AI innovation.
Moshayedi Ventures
Bringing investment and clinical insight into the same conversation.
Moshayedi Investment Group, presented here as Moshayedi Ventures, is led by founder and managing partner Dr. Kevan Moshayedi, MD, FACS. Drawing on more than 30 years of experience in medicine, engineering and technology investment, the group focuses on healthcare and MedTech, artificial intelligence, advanced technologies and telecommunications infrastructure. Its stated investment scope spans Seed through Series D, including co-investment alongside established venture firms.
Moshayedi Ventures is presented alongside the Moshayedi Investment Group profile supplied by its founder and managing partner, Dr. Kevan Moshayedi, MD, FACS. Its investment interests span Seed through Series D and connect the N20 community with venture and growth capital perspectives.
Thank you to Moshayedi Ventures and Dr. Kevan Moshayedi for connecting clinical insight, investment experience and a belief in transformative technology.
Federação Brasileira de Epilepsia (Epilepsia Brasil)
Amplifying the voices of people living with epilepsy.
Federação Brasileira de Epilepsia (Epilepsia Brasil) connects patients, healthcare professionals, researchers and policymakers to advance epilepsy awareness, education, advocacy and scientific collaboration. Its mission includes reducing stigma, improving access to neurological care and encouraging innovation that responds to patients' needs. As an N20 Miami partner, the Federation contributes a patient-centered perspective to international discussions on brain health, neurotechnology and public policy.
The Brazilian Epilepsy Federation brings patient and family experiences into scientific discussions. It advocates for education, reducing stigma, access to care, and collaborative approaches that center people living with epilepsy.
We are especially grateful to Epilepsia Brasil for keeping the lived experience of patients and their families central to global brain-health discussions.
ProgenaBiome
Advancing the science of the gut-brain connection.
ProgenaBiome is a Ventura, California-based genetic research and sequencing laboratory focused on the clinical implications of the gut microbiome. Its work includes next-generation whole-genome shotgun sequencing, microbiome research, assay development and clinical-trial testing. Founded by gastroenterologist Dr. Sabine Hazan, the laboratory collaborates with physicians and researchers to study how microbiome patterns relate to health and disease.
Founded by Dr. Sabine Hazan, ProgenaBiome applies genomic sequencing and clinical research to investigate the human gut microbiome and its relationships with health. Its perspective expands N20 dialogue across the gut-brain connection, precision medicine and translational research.
We thank ProgenaBiome and Dr. Sabine Hazan for helping bring microbiome science into conversations across the broader neuroscience ecosystem.
MEGIN
Seeing brain function with new clarity.
MEGIN develops magnetoencephalography (MEG) technology for non-invasive functional brain mapping. Its MEG Maps™ platform combines the TRIUX™ neo scanner with MEGreview™ to support epilepsy localization, presurgical planning and neuroscience research.
MEGIN works with clinicians, hospitals and research teams to capture and analyze the brain’s magnetic signals. Its clinical workflow connects scanning, functional mapping, secure data management and reporting, helping make advanced MEG studies accessible to care teams and investigators.
We warmly welcome MEGIN to Neuroscience20 Miami and appreciate the company’s commitment to advancing brain imaging, clinical collaboration and tools that help researchers and physicians better understand brain function.
An invitation to collaborate
How your organization can contribute to N20.
Whether your team is advancing science, building technology, funding innovation or advocating for patients, there is room to begin a meaningful conversation.
Scientific & Clinical Collaboration
Connect clinical questions, researchers and technology developers around evidence-driven programs.
Technology & AI Partnerships
Explore collaborations across BCIs, imaging, computational neuroscience, data platforms and intelligent systems.
Investor & Venture Engagement
Meet founders and innovators working to move early-stage science toward real-world implementation.
Institutional & Global Initiatives
Support international dialogue, interdisciplinary education and responsible science policy.
Patient Advocacy & Impact
Bring patient priorities, accessibility and real-world health needs into scientific conversations.
Media & Thought Leadership
Contribute credible expertise and storytelling to conversations shaping future brain health.
Partner with Neuroscience20 Miami
Start with a conversation. Build something meaningful.
Tell us about your organization and what you hope to accomplish. Our team can help explore a connection that fits your goals and the N20 community.
- Scientific & clinical organizations - share research and new approaches to brain health.
- Industry & venture teams - discuss innovation, investment and translational collaboration.
- Patient and nonprofit communities - help keep lived experience at the center of science.
Prefer email? Contact the SBMT partnership team ↗
Partnership questions
Helpful answers, clear next steps.
What partnership opportunities are available?
Neuroscience20 welcomes conversations about corporate partnerships, research and clinical collaboration, innovation showcases, venture engagement, nonprofit and patient advocacy, and scientific or media participation. Use the inquiry form to tell us which area is most relevant.
Where and when is N20 Miami 2026?
The event takes place on Sunday, December 13, 2026, at the Pullman Miami Airport Hotel in Miami, Florida. Visit the main N20 Miami event page for the event overview.
Where can I find partnership details and event information?
Explore the N20 Special Discount Rates & Membership Prospectus and the N20 Program Outline. You can also contact the partnership team through this page.
Can international organizations participate?
Yes. N20 brings together international scientific, industry, policy and patient communities. Tell us your location, goals and preferred type of collaboration in the inquiry form.









